© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
December 20, 2010
Preliminary results of two new targeted therapies, now in late-stage clinical trials, hold much promise for men with hormone-refractory, or castration-resistant, prostate cancer.
New developments in the treatment and management of prostate cancer.
December 09, 2010
New options for advanced prostate cancer mean prolonged remission.
Childhood Cancer Survivor Becomes Oncology Nurse and Hero
A Huge Heart for Patients With Lung Cancer
Imperfection After Breast Cancer
Using Group Therapy as a Learning Experience for Patients With Cancer